FOR IMMEDIATE RELEASE Media Contact BrandStar PR@BrandStar.com (844) 200-2525 Alnylam Pharmaceuticals, Primo Water, West Texas A&M University and Asthma & Allergy Foundation of America take center stage on Lifetime®. (DEERFIELD BEACH, Fla. – PR LOG – May 4, 2016) The Balancing Act ® welcomes experts on hereditary ATTR amyloidosis, home hydration solutions, saving for college and allergies, Thursday, May 5 and May 12, 2016 at 7:30 a.m. (ET/PT) on Lifetime®. Don't miss these special guests on The Balancing Act : Raising Awareness on Hereditary ATTR Amyloidosis – with Alnylam Pharmaceuticals Hereditary ATTR amyloidosis (hATTR amyloidosis) is an inherited, progressive, life-threatening disease. It is due to a mutation in the transthyretin (TTR) gene, which causes misfolded TTR proteins to accumulate as amyloid fibrils in multiple organs, but primarily in the peripheral nerves and heart. hATTR amyloidosis can lead to significant morbidity, disability, and mortality. Its symptoms are diverse
